---
title: "RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283836521.md"
description: "An abstract submission has been accepted as a sub-study within RenovoRx’s Phase III TIGeR-PaC clinical trial. This abstract delves into the TAMP™ therapy platform's ability to enhance local drug potency while decreasing systemic exposure and the typical side effects associated with chemotherapy. This development is a significant component of RenovoRx's ongoing research, with potential implications for increasing treatment efficacy and reducing adverse effects for patients."
datetime: "2026-04-23T12:32:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283836521.md)
  - [en](https://longbridge.com/en/news/283836521.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283836521.md)
---

# RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting

An abstract submission has been accepted as a sub-study within RenovoRx’s Phase III TIGeR-PaC clinical trial. This abstract delves into the TAMP™ therapy platform's ability to enhance local drug potency while decreasing systemic exposure and the typical side effects associated with chemotherapy. This development is a significant component of RenovoRx's ongoing research, with potential implications for increasing treatment efficacy and reducing adverse effects for patients.

### Related Stocks

- [RNXT.US](https://longbridge.com/en/quote/RNXT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)

## Related News & Research

- [Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study | DWTX Stock News](https://longbridge.com/en/news/286772955.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [RenovoRx Q1 revenue rises as number of active cancer centers increase](https://longbridge.com/en/news/286462396.md)
- [MIRA Pharmaceuticals Reports Positive Phase 1 Ketamir-2 Results](https://longbridge.com/en/news/286319406.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)